Nathan Rice
Stock Analyst at Piper Sandler
(3.05)
# 1,233
Out of 5,241 analysts
64
Total ratings
50%
Success rate
11.24%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FMBH First Mid Bancshares | Reiterates: Overweight | $52 → $55 | $42.10 | +30.64% | 6 | May 1, 2026 | |
| BY Byline Bancorp | Maintains: Overweight | $37 → $40 | $32.24 | +24.07% | 10 | Apr 27, 2026 | |
| BFC Bank First | Maintains: Neutral | $150 → $157 | $141.80 | +10.72% | 11 | Apr 20, 2026 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $44.75 | -6.15% | 9 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $97.56 | -24.15% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $137.47 | -38.90% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $159.77 | +23.30% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $21.02 | -57.18% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $535.90 | -18.83% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $292.68 | -20.39% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $58.74 | +41.30% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $20.56 | -27.04% | 1 | Dec 19, 2019 |
First Mid Bancshares
May 1, 2026
Reiterates: Overweight
Price Target: $52 → $55
Current: $42.10
Upside: +30.64%
Byline Bancorp
Apr 27, 2026
Maintains: Overweight
Price Target: $37 → $40
Current: $32.24
Upside: +24.07%
Bank First
Apr 20, 2026
Maintains: Neutral
Price Target: $150 → $157
Current: $141.80
Upside: +10.72%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $44.75
Upside: -6.15%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $97.56
Upside: -24.15%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $137.47
Upside: -38.90%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $159.77
Upside: +23.30%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $21.02
Upside: -57.18%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $535.90
Upside: -18.83%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $292.68
Upside: -20.39%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $58.74
Upside: +41.30%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $20.56
Upside: -27.04%